Osaic Holdings
ALXN

Osaic Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Osaic Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,157
Closed -$1.86M – 7543
2021
Q2 		$1.86M Sell
10,157
-1,673
-14% -$287K ﹤0.01% 1791
2021
Q1 		$1.81M Sell
11,830
-15,001
-56% -$2.32M ﹤0.01% 1712
2020
Q4 		$4.19M Sell
26,831
-1,379
-5% -$177K 0.01% 948
2020
Q3 		$3.23M Buy
28,210
+601
+2% +$64.8K 0.01% 1012
2020
Q2 		$3.09M Buy
27,609
+4,064
+17% +$431K 0.01% 974
2020
Q1 		$1.95M Buy
+23,545
New +$2.31M 0.01% 1087

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return